Latest Breaking News On - தாவல் தேசாய் - Page 1 : comparemela.com

Operator Good morning, and welcome to the Iveric Bio first-quarter 2021 earnings conference call. [Operator instructions] Please note this call is being recorded. I would now like to turn the conference over to Kathy Galante, senior vice president, investor relations. Please go ahead. Kathy Galante Senior Vice President, Investor Relations Good morning, and welcome to Iveric Bio s conference call. Representing Iveric Bio today are Glenn Sblendorio, chief executive officer; Pravin Dugel, president; David Carroll, chief financial officer; Dhaval Desai, chief development officer; Abraham Scaria, chief scientific officer; and Keith Westby, chief operating officer. I would like to remind you that today, we will be making statements relating to Iveric Bio s future expectations regarding operational, financial and research and development matters, including statements regarding our expectations for patient enrollment and patient retention in GATHER2, our second Phase 3 clinical trial

Nordrhein westfalenUnited statesTel avivKeith westbyStacy ku cowenIveric bioCharles wykoffAndreas lauerDavid nierengartenBart leroyDavid guyerDavid carrollTrent woodruffPravin dugelStacy kuDavid nierengarten wedbush